Pricing Log in Create free account

60 Degrees Pharmaceuticals Inc. (SXTP) vs Traws Pharma, Inc. (TRAW)

60 Degrees Pharmaceuticals Inc. and Traws Pharma, Inc. are both Biotechnology companies. 60 Degrees Pharmaceuticals Inc. and Traws Pharma, Inc. are of similar size ($3.4M and $3.2M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against 23.4%. Traws Pharma, Inc. has the higher net margin (0.00% vs −678.0%) and the higher return on invested capital (0.00% vs −348.6%). Across the 16 metrics below, Traws Pharma, Inc. leads on 14 and 60 Degrees Pharmaceuticals Inc. on 2.

Valuation

Metric SXTP TRAW Biotechnology median
P/E n/m n/m 10.60
P/S 1.31 1.28 9.40
P/B n/m 2.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.06 0.66
EV/Sales 1.47 (0.48) 9.02
Earnings yield (1,046.67%) (656.52%) (32.88%)
Free cash flow yield (569.15%) (462.16%) (23.13%)

Profitability

Metric SXTP TRAW Biotechnology median
Gross margin 43.42% 100.00% 68.51%
Operating margin (691.33%) 0.00% 0.00%
Net margin (678.03%) 0.00% 0.00%
Free cash flow margin (745.93%) 0.00% 0.00%
Return on equity 115.54% (336.30%) (51.96%)
Return on assets (194.65%) (123.55%) (46.06%)
Return on invested capital (348.64%) 0.00% 0.00%

Growth

Metric SXTP TRAW Biotechnology median
Revenue growth (TTM) 23.41% 1,159.29% 6.76%
EPS growth (last fiscal year) 84.19% 102.33% 29.88%
Revenue growth, 5-year CAGR (11.18%) 64.59% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SXTP TRAW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 0.93 4.97
Net debt to EBITDA 0.37 0.21 1.01

Dividend

Metric SXTP TRAW Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SXTP TRAW Biotechnology median
Market cap 3.22m 3.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack